Wikidata entity: Q99956427
Quantities
| P4135 | maximum age | 75 |
| P2899 | minimum age | 18 |
| P1132 | number of participants | 53 |
| P6099 | clinical trial phase | ... | Q42824440 (phase II clinical trial) | phase II clinical trial |
| P582 | end time | ... | 2023-05-01 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P6153 | research site | ... | Q11102507 (Hangzhou First People's Hospital) | Hangzhou First People's Hospital |
| P8005 | research subject recruitment status | ... | Q76649614 (not yet recruiting) | not yet recruiting |
| P1813 | short name | Monolingualtext | AUTUMN | ??? |
| P580 | start time | ... | 2020-11-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | Almonertinib as Upfront Treatment for Uncommon EGFR Mutation Harboring Non-Small-Cell Lung Cancer Patients: A Multicenter, Open-Label, Phase II Trial | ??? |
| P3098 | ClinicalTrials.gov ID | NCT04553887 |
Why not click here or view trends?
log id: 4706530